{"id":181021,"date":"2022-01-05T00:55:12","date_gmt":"2022-01-04T19:25:12","guid":{"rendered":"https:\/\/arunachaltimes.in\/?p=181021"},"modified":"2022-01-05T00:55:12","modified_gmt":"2022-01-04T19:25:12","slug":"dr-reddys-to-launch-molflu-at-rs-35-per-capsule-for-covid-treatment","status":"publish","type":"post","link":"https:\/\/arunachaltimes.in\/index.php\/2022\/01\/05\/dr-reddys-to-launch-molflu-at-rs-35-per-capsule-for-covid-treatment\/","title":{"rendered":"Dr Reddy\u2019s to launch Molflu at Rs 35 per capsule for COVID treatment"},"content":{"rendered":"<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">New Delhi, Jan 4 (PTI): Dr Reddy\u2019s Laboratories on Tuesday said it will launch Molflu (Molnupiravir) at Rs 35 per capsule to treat COVID-19 in the country.Molflu will be priced at Rs 35 per capsule, a spokesperson of the Hyderabad-based drug maker said in a statement.With 10 capsules per strip, the total course of 40 capsules over 5 days would cost Rs 1,400, making it among the most affordable treatment options available to patients, it added.<\/p>\n<p style=\"text-align: justify;\">\u201cMolflu is expected to be available from early next week in pharmacies throughout the country with particular focus on states with high caseload of COVID-19,\u201d the spokesperson noted.Last year, Dr Reddy\u2019s entered into a non-exclusive voluntary licensing agreement with Merck Sharpe Dohme (MSD) to manufacture and supply Molnupiravir to India and over 100 low and middle-income countries (LMICs).<\/p>\n<p style=\"text-align: justify;\">In a first-of-its-kind collaboration in the Indian pharmaceutical industry, a Dr Reddy\u2019s-led consortium of pharma companies collaborated to jointly sponsor, supervise and monitor the Phase III clinical trial of Molnupiravir in India, and presented its findings to the Subject Expert Committee.<\/p>\n<p style=\"text-align: justify;\">Last week, Dr Reddy\u2019s received emergency-use authorisation from the Drugs Controller General of India (DCGI) to manufacture and market oral antiviral drug Molnupiravir capsules 200 mg for the treatment of adult patients with COVID-19 who have high risk of progression of the disease including hospitalisation or death.Molflu will be manufactured at a USFDA-approved facility, and the drug maker has made adequate capacity preparations to ensure that it is able to help patients in need, it said.<\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">\n","protected":false},"excerpt":{"rendered":"<p>New Delhi, Jan 4 (PTI): Dr Reddy\u2019s Laboratories on Tuesday said it will launch Molflu (Molnupiravir) at Rs 35 per capsule to treat COVID-19 in the country.Molflu will be priced at Rs 35 per capsule, a spokesperson of the Hyderabad-based drug maker said in a statement.With 10 capsules per strip, the total course of 40 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":{"0":"post-181021","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-national"},"_links":{"self":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/posts\/181021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/comments?post=181021"}],"version-history":[{"count":0,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/posts\/181021\/revisions"}],"wp:attachment":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/media?parent=181021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/categories?post=181021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/tags?post=181021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}